Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined bisoprolol and trimetazidine ameliorate arsenic trioxide -induced acute myocardial injury in rats: targeting PI3K/GSK-3β/Nrf2/HO-1 and NF-κB/iNOS signaling pathways, inflammatory mediators and apoptosis.
Ahmed YM, El-Shoura EAM, Kozman MR, Abdel-Wahab BA, Abdel-Sattar AR. Ahmed YM, et al. Among authors: el shoura eam. Immunopharmacol Immunotoxicol. 2025 Feb;47(1):68-84. doi: 10.1080/08923973.2024.2435323. Epub 2024 Dec 9. Immunopharmacol Immunotoxicol. 2025. PMID: 39604018
Corrigendum to "Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways" [Int. Immunopharmacol. 140 (2024) 112777].
El-Shoura EAM, Mohamed AAN, Atwa AM, Salem EA, Sharkawi SMZ, Selim HM, Elberri AI, Gawesh ES, Ahmed YH, Abd El-Ghafar OAM. El-Shoura EAM, et al. Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113557. doi: 10.1016/j.intimp.2024.113557. Epub 2024 Nov 20. Int Immunopharmacol. 2024. PMID: 39572317 No abstract available.
Corrigendum to "Combined sulforaphane and β-sitosterol mitigate against olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways" [Int. Immunopharmacol. 140 (2024) 112904].
El-Shoura EAM, Abdelzaher LA, Mahmoud NI, Farghaly OA, Sabry M, Shahataa MG, Salem EA, Saad HM, Elhussieny O, Kozman MR, Atwa AM. El-Shoura EAM, et al. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113556. doi: 10.1016/j.intimp.2024.113556. Epub 2024 Nov 8. Int Immunopharmacol. 2024. PMID: 39516064 No abstract available.
Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways.
El-Shoura EAM, Abdelzaher LA, Mahmoud NI, Farghaly OA, Sabry M, Girgis Shahataa M, Salem EA, Saad HM, Elhussieny O, Kozman MR, Atwa AM. El-Shoura EAM, et al. Int Immunopharmacol. 2024 Oct 25;140:112904. doi: 10.1016/j.intimp.2024.112904. Epub 2024 Aug 7. Int Immunopharmacol. 2024. PMID: 39116489
Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways.
El-Shoura EAM, Mohamed AAN, Atwa AM, Salem EA, Sharkawi SMZ, Mostafa Selim H, Ibrahim Elberri A, Gawesh ES, Ahmed YH, Abd El-Ghafar OAM. El-Shoura EAM, et al. Int Immunopharmacol. 2024 Oct 25;140:112777. doi: 10.1016/j.intimp.2024.112777. Epub 2024 Aug 2. Int Immunopharmacol. 2024. PMID: 39088923
28 results